Cargando…

Identification of Liver Cancer Stem Cell Stemness Markers Using a Comparative Analysis of Public Data Sets

PURPOSE: Comparative reanalysis of single-cell transcriptomics data to gain useful novel insights into cancer stem cells (CSCs), which are a rare subset of cells within tumors, characterized by their capability to self-renew and differentiate, and their role in tumorigenicity. PATIENTS AND METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Borziak, Kirill, Finkelstein, Joseph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216768/
https://www.ncbi.nlm.nih.gov/pubmed/34168465
http://dx.doi.org/10.2147/SCCAA.S307043
_version_ 1783710484993671168
author Borziak, Kirill
Finkelstein, Joseph
author_facet Borziak, Kirill
Finkelstein, Joseph
author_sort Borziak, Kirill
collection PubMed
description PURPOSE: Comparative reanalysis of single-cell transcriptomics data to gain useful novel insights into cancer stem cells (CSCs), which are a rare subset of cells within tumors, characterized by their capability to self-renew and differentiate, and their role in tumorigenicity. PATIENTS AND METHODS: This project utilized publically available liver single-cell RNA-seq datasets of liver cancer and liver progenitor cell types to demonstrate how shared large amounts of data can generate new and valuable information. The data were analyzed using EdgeR differential expression analysis, with focus on a set of 34 known stemness markers. RESULTS: We showed that the expression of stemness markers SOX9, KRT19, KRT7, and CD24, and Yamanaka factors Oct4 and SOX2 in CSCs was significantly elevated relative to progenitor cell types, potentially explaining their increased differentiation and replication potential. CONCLUSION: These results help to further document the complementary expression changes that give CSCs their distinct phenotypic profile. Our findings have potential significance to advance our knowledge of the important genes relevant to CSCs.
format Online
Article
Text
id pubmed-8216768
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-82167682021-06-23 Identification of Liver Cancer Stem Cell Stemness Markers Using a Comparative Analysis of Public Data Sets Borziak, Kirill Finkelstein, Joseph Stem Cells Cloning Original Research PURPOSE: Comparative reanalysis of single-cell transcriptomics data to gain useful novel insights into cancer stem cells (CSCs), which are a rare subset of cells within tumors, characterized by their capability to self-renew and differentiate, and their role in tumorigenicity. PATIENTS AND METHODS: This project utilized publically available liver single-cell RNA-seq datasets of liver cancer and liver progenitor cell types to demonstrate how shared large amounts of data can generate new and valuable information. The data were analyzed using EdgeR differential expression analysis, with focus on a set of 34 known stemness markers. RESULTS: We showed that the expression of stemness markers SOX9, KRT19, KRT7, and CD24, and Yamanaka factors Oct4 and SOX2 in CSCs was significantly elevated relative to progenitor cell types, potentially explaining their increased differentiation and replication potential. CONCLUSION: These results help to further document the complementary expression changes that give CSCs their distinct phenotypic profile. Our findings have potential significance to advance our knowledge of the important genes relevant to CSCs. Dove 2021-06-16 /pmc/articles/PMC8216768/ /pubmed/34168465 http://dx.doi.org/10.2147/SCCAA.S307043 Text en © 2021 Borziak and Finkelstein. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Borziak, Kirill
Finkelstein, Joseph
Identification of Liver Cancer Stem Cell Stemness Markers Using a Comparative Analysis of Public Data Sets
title Identification of Liver Cancer Stem Cell Stemness Markers Using a Comparative Analysis of Public Data Sets
title_full Identification of Liver Cancer Stem Cell Stemness Markers Using a Comparative Analysis of Public Data Sets
title_fullStr Identification of Liver Cancer Stem Cell Stemness Markers Using a Comparative Analysis of Public Data Sets
title_full_unstemmed Identification of Liver Cancer Stem Cell Stemness Markers Using a Comparative Analysis of Public Data Sets
title_short Identification of Liver Cancer Stem Cell Stemness Markers Using a Comparative Analysis of Public Data Sets
title_sort identification of liver cancer stem cell stemness markers using a comparative analysis of public data sets
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216768/
https://www.ncbi.nlm.nih.gov/pubmed/34168465
http://dx.doi.org/10.2147/SCCAA.S307043
work_keys_str_mv AT borziakkirill identificationoflivercancerstemcellstemnessmarkersusingacomparativeanalysisofpublicdatasets
AT finkelsteinjoseph identificationoflivercancerstemcellstemnessmarkersusingacomparativeanalysisofpublicdatasets